Interpharma members currently invest around CHF 6.5 billion a year in research and development in Switzerland.
Accounting for 46% of all exports, the EU was the Swiss pharmaceutical industry's biggest trading partner in 2019.
Our mission is to ensure that patients in Switzerland receive access to innovative medicines and therapies as quickly as possible.
People in Switzerland benefit from access to high-quality healthcare provision. However, there is still a need for action and improvement in various areas.
show more articles
Interpharma, the association of Switzerland’s research-based pharmaceutical industry, was founded in Basel in 1933.
Interpharma informs the public about issues that are important to the research-based pharmaceutical industry in Switzerland, including the pharma market in Switzerland, healthcare and biomedical research.
Information on our key figures and activities in the financial year 2019
More about the tasks and overriding aims of Interpharma
Latest information and media contacts for media representatives